Kettle Hill Capital Management’s Inspire Medical Systems INSP Stock Holding History

Kettle Hill Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,715	Closed	-$1.09M	–	38
2018 Q2	$1.09M	Buy	+30,715	New	+$991K	0.42%	28

Other funds holding INSP

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Kettle Hill Capital Management's INSP Position: Q3 2018 in Review

Kettle Hill Capital Management sold out of Inspire Medical Systems (INSP) in Q3 2018, closing a stake of 30,715 shares — an estimated $1.09M sold.

Kettle Hill Capital Management first reported a position in INSP in Q2 2018 and held it in 1 quarter. The position peaked at $1.09M in Q2 2018. 87 funds tracked by Wall St. Rank hold INSP as of Q3 2018.

Kettle Hill Capital Management reported no remaining Inspire Medical Systems position as of Q3 2018 after selling out during the quarter.
Kettle Hill Capital Management sold 30,715 Inspire Medical Systems shares in Q3 2018, an estimated $1.09M.
Kettle Hill Capital Management first reported a position in Inspire Medical Systems in Q2 2018 and held it in 1 quarter.
Kettle Hill Capital Management's Inspire Medical Systems position peaked at $1.09M in Q2 2018.
87 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2018.

Based on Kettle Hill Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.